Industry: Biotechnology (See others in industry)
Address:Date | FilingType | Incremental Cash | Link to Raw Filing | |||
---|---|---|---|---|---|---|
2025-05-06 | New | $198,128,718 | $198,128,718 | Equity Only | 06b | SEC link |
2024-07-25 | New | $2,730,612 | $2,730,612 | Equity and Debt | 06b | SEC link |
2024-03-08 | New | $2,275,000 | $2,275,000 | Equity and Debt | 06b | SEC link |
2023-07-26 | New | $75,843,150 | $75,843,150 | Equity Only | 06b | SEC link |
2018-12-20 | New | $20,365,906 | $20,365,906 | Equity Only | 06b | SEC link |
2017-10-18 | New | $20,705,024 | $20,705,024 | Equity Only | 06b | SEC link |
2016-05-04 | New | $6,769,997 | $6,769,997 | Equity Only | 06b | SEC link |
2014-02-25 | Amended | $1,563,572 | $549,990 | Equity Only | 06b | SEC link |
2014-01-03 | New | $1,013,582 | $1,013,582 | Equity Only | 06b | SEC link |
2011-06-01 | New | $2,708,236 | $2,708,236 | Equity Only | 06 | SEC link |
Name | Role |
---|---|
James Alecxih | Director |
Moungi Bawendi | Director |
Elon Boms | Director |
Jorge Ferrer | Executive |
Cosimo Fiorenza | Director |
David Furneaux | Director |
Carlos Gonzalez | Director |
Howard Hechler | Director, Executive |
Kevin Hershberger | Director, Executive |
William D. Johnson | Executive |
Kevin Krenitsky | Director |
W. David Lee | Director |
Kelly Londy | Director, Executive |
Michael Ruettgers | Director |
Mike Ruettgers | Director |
James Schuermann | Director |
Ralph Weissleder | Director |
Andrey J. Zarur | Director |